ChondroNest SA

Ecosystem

Where to find us

Building

Entry

Floor

In vivo reconstruction of the scaffold of the Extra Cellular Matrix – ECM – with mechanical and biocompatible properties based on the natural biopolymers of living tissues. The intellectual property filed is centred on an innovative chemical approach for the modification of the proteins (Collagens, Fibronectins, etc) and Glycosaminoglycans (Hyaluronic acid, Chondroitin sulphate, and so forth).

Main sector

Biotech

Specialties

Core competencies

Diagnostic & In-Vitro Device, Medical Technology, Orthopaedic & Rehabilitation, Proteins & Peptides

Organization Type

Private Company

Key Businesses

Entreprise
Scroll to Top